Connect with us

Abilify (aripiprazole)

Aripiprazole (or ABILIFY®) is mainly prescribed to treat schizophrenia, bipolar disorder, and major depressive disorder.

Status: ACTIVE

Class: Atypical (AAP)

FDA Approval: 2002

Dosage Forms: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg

Biological Half-life: 75 hours

Side Effects: Dizziness, nausea, orthostatic hypotension, constipation, headache, movement problems

Routes of Administration: Oral, Sublingual, IM, IV

Pregnancy Category: C (US)


Twitter Feed

Major depression or bipolar disorder? EKG can help determine the correct diagnosis

Amazon might be eyeing the prescription drug market

Naloxone nasal spray as effective as injection for reversing opioid overdoses #OpioidCrisis